8 December 2021 - Pfizer CEO Albert Bourla said he’s confident the full results from the clinical trials will show that the oral antiviral pill, Paxlovid, reduces hospitalization and death by 89%.
Pfizer will submit full data on its Covid treatment pill to the FDA in the coming days, CEO Albert Bourla told CNBC on Wednesday.